E.g., in COVID-19, median CRP levels were 15.6 mg/dL (IQR 1.6–46.7) in event-free survivors as compared to 112.6 mg/dL (IQR 47.6–162.7) in patients with the primary composite outcome (p < 0.001). This evidence concerns the gene CRP and COVID-19.